HEADER RNA BINDING PROTEIN 16-MAY-24 9FCV TITLE CAS NUCLEASE-CRISPR (CR)RNA RIBONUCLEOPROTEIN (RNP) COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHAGE HEAD-TAIL ADAPTOR; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: CRRNA; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: UNPROCESSED CRRNA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEGATELLA BUCCAE; SOURCE 3 ORGANISM_TAXID: 28126; SOURCE 4 GENE: HMPREF6485_0083; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 10 ORGANISM_TAXID: 32630 KEYWDS ACRVIB1; ANTI-CRISPR PROTEIN; CAS13B, RNA BINDING PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.SCHMELZ,P.LUKAT,W.BLANKENFELDT REVDAT 3 02-APR-25 9FCV 1 JRNL REVDAT 2 05-MAR-25 9FCV 1 JRNL REVDAT 1 12-FEB-25 9FCV 0 JRNL AUTH K.G.WANDERA,S.SCHMELZ,A.MIGUR,A.KIBE,P.LUKAT,T.ACHMEDOV, JRNL AUTH 2 N.CALISKAN,W.BLANKENFELDT,C.L.BEISEL JRNL TITL ACRVIB1 INHIBITS CRISPR-CAS13B IMMUNITY BY PROMOTING JRNL TITL 2 UNPRODUCTIVE CRRNA BINDING ACCESSIBLE TO RNASE ATTACK. JRNL REF MOL.CELL V. 85 1162 2025 JRNL REFN ISSN 1097-2765 JRNL PMID 39965569 JRNL DOI 10.1016/J.MOLCEL.2025.01.020 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.LIEBSCHNER,P.V.AFONINE,M.L.BAKER,G.BUNKOCZI,V.B.CHEN, REMARK 1 AUTH 2 T.I.CROLL,B.HINTZE,L.W.HUNG,S.JAIN,A.J.MCCOY,N.W.MORIARTY, REMARK 1 AUTH 3 R.D.OEFFNER,B.K.POON,M.G.PRISANT,R.J.READ,J.S.RICHARDSON, REMARK 1 AUTH 4 D.C.RICHARDSON,M.D.SAMMITO,O.V.SOBOLEV,D.H.STOCKWELL, REMARK 1 AUTH 5 T.C.TERWILLIGER,A.G.URZHUMTSEV,L.L.VIDEAU,C.J.WILLIAMS, REMARK 1 AUTH 6 P.D.ADAMS REMARK 1 TITL MACROMOLECULAR STRUCTURE DETERMINATION USING X-RAYS, REMARK 1 TITL 2 NEUTRONS AND ELECTRONS: RECENT DEVELOPMENTS IN PHENIX REMARK 1 REF ACTA CRYSTALLOGR., SECT. D: V. 75 861 2019 REMARK 1 REF 2 BIOL. CRYSTALLOGR. REMARK 1 REFN ISSN 0907-4449 REMARK 1 PMID 31588918 REMARK 1 DOI 10.1107/S2059798319011471 REMARK 2 REMARK 2 RESOLUTION. 3.09 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CRYOSPARC, EPU, CRYOSPARC, UCSF REMARK 3 CHIMERAX, COOT, PHENIX, CRYOSPARC, REMARK 3 CRYOSPARC, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 6DTD REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.090 REMARK 3 NUMBER OF PARTICLES : 356629 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9FCV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 16-MAY-24. REMARK 100 THE DEPOSITION ID IS D_1292138632. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CAS13B (CR)RNA COMPLEX REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00 REMARK 245 SAMPLE SUPPORT DETAILS : 15 MA REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 3778 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS GLACIOS REMARK 245 DETECTOR TYPE : TFS FALCON 4I (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 600.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLN A 2 REMARK 465 LYS A 3 REMARK 465 GLN A 4 REMARK 465 ASP A 5 REMARK 465 LYS A 6 REMARK 465 LEU A 7 REMARK 465 PHE A 8 REMARK 465 VAL A 9 REMARK 465 ASP A 10 REMARK 465 ARG A 11 REMARK 465 LYS A 12 REMARK 465 LYS A 13 REMARK 465 ASN A 14 REMARK 465 ALA A 15 REMARK 465 ILE A 16 REMARK 465 PHE A 17 REMARK 465 ALA A 18 REMARK 465 PHE A 19 REMARK 465 PRO A 20 REMARK 465 LYS A 21 REMARK 465 TYR A 22 REMARK 465 ILE A 23 REMARK 465 THR A 24 REMARK 465 ILE A 25 REMARK 465 MET A 26 REMARK 465 GLU A 27 REMARK 465 ASN A 28 REMARK 465 LYS A 29 REMARK 465 GLU A 30 REMARK 465 LYS A 31 REMARK 465 PRO A 32 REMARK 465 GLU A 33 REMARK 465 PRO A 34 REMARK 465 ILE A 35 REMARK 465 VAL A 217 REMARK 465 GLY A 218 REMARK 465 ARG A 219 REMARK 465 THR A 220 REMARK 465 LYS A 221 REMARK 465 ASN A 222 REMARK 465 ILE A 337 REMARK 465 PHE A 338 REMARK 465 SER A 339 REMARK 465 ASP A 340 REMARK 465 ASP A 341 REMARK 465 TYR A 342 REMARK 465 ASN A 343 REMARK 465 ALA A 344 REMARK 465 GLU A 345 REMARK 465 GLU A 346 REMARK 465 ASP A 432 REMARK 465 LEU A 433 REMARK 465 ASP A 434 REMARK 465 HIS A 435 REMARK 465 PHE A 436 REMARK 465 GLU A 437 REMARK 465 THR A 898 REMARK 465 VAL A 899 REMARK 465 GLU A 900 REMARK 465 GLY A 901 REMARK 465 LEU A 902 REMARK 465 LYS A 903 REMARK 465 ILE A 904 REMARK 465 SER A 1095 REMARK 465 VAL A 1096 REMARK 465 ASP A 1097 REMARK 465 THR A 1098 REMARK 465 LYS A 1126 REMARK 465 ASN A 1127 REMARK 465 C B 2 REMARK 465 G B 3 REMARK 465 U B 4 REMARK 465 C B 5 REMARK 465 G B 6 REMARK 465 C B 7 REMARK 465 C B 8 REMARK 465 G B 9 REMARK 465 U B 10 REMARK 465 C B 11 REMARK 465 C B 12 REMARK 465 A B 13 REMARK 465 G B 14 REMARK 465 C B 15 REMARK 465 U B 16 REMARK 465 C B 17 REMARK 465 G B 18 REMARK 465 A B 19 REMARK 465 C B 20 REMARK 465 C B 21 REMARK 465 A B 22 REMARK 465 G B 23 REMARK 465 G B 24 REMARK 465 U B 69 REMARK 465 C B 70 REMARK 465 G B 71 REMARK 465 U B 72 REMARK 465 C B 73 REMARK 465 C B 74 REMARK 465 A B 75 REMARK 465 U B 76 REMARK 465 U B 77 REMARK 465 C B 78 REMARK 465 C B 79 REMARK 465 G B 80 REMARK 465 A B 81 REMARK 465 C B 82 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 369 OH TYR A 451 2.07 REMARK 500 OD1 ASN A 653 O2' C B 67 2.12 REMARK 500 NZ LYS A 151 O ILE A 172 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 73 -167.37 -79.85 REMARK 500 SER A 168 171.08 65.15 REMARK 500 PRO A 169 6.36 -68.73 REMARK 500 LYS A 170 73.25 59.78 REMARK 500 PRO A 171 75.25 -65.30 REMARK 500 TYR A 196 41.94 -107.16 REMARK 500 CYS A 284 33.19 -140.75 REMARK 500 ALA A 495 147.60 -172.49 REMARK 500 ASN A 648 30.26 70.36 REMARK 500 PHE A 696 24.56 -140.49 REMARK 500 THR A 989 -122.28 54.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-50322 RELATED DB: EMDB REMARK 900 CAS NUCLEASE-CRISPR (CR)RNA RIBONUCLEOPROTEIN (RNP) COMPLEX DBREF 9FCV A 1 1127 UNP E6K398 E6K398_9BACT 1 1127 DBREF 9FCV B 2 82 PDB 9FCV 9FCV 2 82 SEQRES 1 A 1127 MET GLN LYS GLN ASP LYS LEU PHE VAL ASP ARG LYS LYS SEQRES 2 A 1127 ASN ALA ILE PHE ALA PHE PRO LYS TYR ILE THR ILE MET SEQRES 3 A 1127 GLU ASN LYS GLU LYS PRO GLU PRO ILE TYR TYR GLU LEU SEQRES 4 A 1127 THR ASP LYS HIS PHE TRP ALA ALA PHE LEU ASN LEU ALA SEQRES 5 A 1127 ARG HIS ASN VAL TYR THR THR ILE ASN HIS ILE ASN ARG SEQRES 6 A 1127 ARG LEU GLU ILE ALA GLU LEU LYS ASP ASP GLY TYR MET SEQRES 7 A 1127 MET GLY ILE LYS GLY SER TRP ASN GLU GLN ALA LYS LYS SEQRES 8 A 1127 LEU ASP LYS LYS VAL ARG LEU ARG ASP LEU ILE MET LYS SEQRES 9 A 1127 HIS PHE PRO PHE LEU GLU ALA ALA ALA TYR GLU MET THR SEQRES 10 A 1127 ASN SER LYS SER PRO ASN ASN LYS GLU GLN ARG GLU LYS SEQRES 11 A 1127 GLU GLN SER GLU ALA LEU SER LEU ASN ASN LEU LYS ASN SEQRES 12 A 1127 VAL LEU PHE ILE PHE LEU GLU LYS LEU GLN VAL LEU ARG SEQRES 13 A 1127 ASN TYR TYR SER HIS TYR LYS TYR SER GLU GLU SER PRO SEQRES 14 A 1127 LYS PRO ILE PHE GLU THR SER LEU LEU LYS ASN MET TYR SEQRES 15 A 1127 LYS VAL PHE ASP ALA ASN VAL ARG LEU VAL LYS ARG ASP SEQRES 16 A 1127 TYR MET HIS HIS GLU ASN ILE ASP MET GLN ARG ASP PHE SEQRES 17 A 1127 THR HIS LEU ASN ARG LYS LYS GLN VAL GLY ARG THR LYS SEQRES 18 A 1127 ASN ILE ILE ASP SER PRO ASN PHE HIS TYR HIS PHE ALA SEQRES 19 A 1127 ASP LYS GLU GLY ASN MET THR ILE ALA GLY LEU LEU PHE SEQRES 20 A 1127 PHE VAL SER LEU PHE LEU ASP LYS LYS ASP ALA ILE TRP SEQRES 21 A 1127 MET GLN LYS LYS LEU LYS GLY PHE LYS ASP GLY ARG ASN SEQRES 22 A 1127 LEU ARG GLU GLN MET THR ASN GLU VAL PHE CYS ARG SER SEQRES 23 A 1127 ARG ILE SER LEU PRO LYS LEU LYS LEU GLU ASN VAL GLN SEQRES 24 A 1127 THR LYS ASP TRP MET GLN LEU ASP MET LEU ASN GLU LEU SEQRES 25 A 1127 VAL ARG CYS PRO LYS SER LEU TYR GLU ARG LEU ARG GLU SEQRES 26 A 1127 LYS ASP ARG GLU SER PHE LYS VAL PRO PHE ASP ILE PHE SEQRES 27 A 1127 SER ASP ASP TYR ASN ALA GLU GLU GLU PRO PHE LYS ASN SEQRES 28 A 1127 THR LEU VAL ARG HIS GLN ASP ARG PHE PRO TYR PHE VAL SEQRES 29 A 1127 LEU ARG TYR PHE ASP LEU ASN GLU ILE PHE GLU GLN LEU SEQRES 30 A 1127 ARG PHE GLN ILE ASP LEU GLY THR TYR HIS PHE SER ILE SEQRES 31 A 1127 TYR ASN LYS ARG ILE GLY ASP GLU ASP GLU VAL ARG HIS SEQRES 32 A 1127 LEU THR HIS HIS LEU TYR GLY PHE ALA ARG ILE GLN ASP SEQRES 33 A 1127 PHE ALA PRO GLN ASN GLN PRO GLU GLU TRP ARG LYS LEU SEQRES 34 A 1127 VAL LYS ASP LEU ASP HIS PHE GLU THR SER GLN GLU PRO SEQRES 35 A 1127 TYR ILE SER LYS THR ALA PRO HIS TYR HIS LEU GLU ASN SEQRES 36 A 1127 GLU LYS ILE GLY ILE LYS PHE CYS SER ALA HIS ASN ASN SEQRES 37 A 1127 LEU PHE PRO SER LEU GLN THR ASP LYS THR CYS ASN GLY SEQRES 38 A 1127 ARG SER LYS PHE ASN LEU GLY THR GLN PHE THR ALA GLU SEQRES 39 A 1127 ALA PHE LEU SER VAL HIS GLU LEU LEU PRO MET MET PHE SEQRES 40 A 1127 TYR TYR LEU LEU LEU THR LYS ASP TYR SER ARG LYS GLU SEQRES 41 A 1127 SER ALA ASP LYS VAL GLU GLY ILE ILE ARG LYS GLU ILE SEQRES 42 A 1127 SER ASN ILE TYR ALA ILE TYR ASP ALA PHE ALA ASN ASN SEQRES 43 A 1127 GLU ILE ASN SER ILE ALA ASP LEU THR ARG ARG LEU GLN SEQRES 44 A 1127 ASN THR ASN ILE LEU GLN GLY HIS LEU PRO LYS GLN MET SEQRES 45 A 1127 ILE SER ILE LEU LYS GLY ARG GLN LYS ASP MET GLY LYS SEQRES 46 A 1127 GLU ALA GLU ARG LYS ILE GLY GLU MET ILE ASP ASP THR SEQRES 47 A 1127 GLN ARG ARG LEU ASP LEU LEU CYS LYS GLN THR ASN GLN SEQRES 48 A 1127 LYS ILE ARG ILE GLY LYS ARG ASN ALA GLY LEU LEU LYS SEQRES 49 A 1127 SER GLY LYS ILE ALA ASP TRP LEU VAL ASN ASP MET MET SEQRES 50 A 1127 ARG PHE GLN PRO VAL GLN LYS ASP GLN ASN ASN ILE PRO SEQRES 51 A 1127 ILE ASN ASN SER LYS ALA ASN SER THR GLU TYR ARG MET SEQRES 52 A 1127 LEU GLN ARG ALA LEU ALA LEU PHE GLY SER GLU ASN PHE SEQRES 53 A 1127 ARG LEU LYS ALA TYR PHE ASN GLN MET ASN LEU VAL GLY SEQRES 54 A 1127 ASN ASP ASN PRO HIS PRO PHE LEU ALA GLU THR GLN TRP SEQRES 55 A 1127 GLU HIS GLN THR ASN ILE LEU SER PHE TYR ARG ASN TYR SEQRES 56 A 1127 LEU GLU ALA ARG LYS LYS TYR LEU LYS GLY LEU LYS PRO SEQRES 57 A 1127 GLN ASN TRP LYS GLN TYR GLN HIS PHE LEU ILE LEU LYS SEQRES 58 A 1127 VAL GLN LYS THR ASN ARG ASN THR LEU VAL THR GLY TRP SEQRES 59 A 1127 LYS ASN SER PHE ASN LEU PRO ARG GLY ILE PHE THR GLN SEQRES 60 A 1127 PRO ILE ARG GLU TRP PHE GLU LYS HIS ASN ASN SER LYS SEQRES 61 A 1127 ARG ILE TYR ASP GLN ILE LEU SER PHE ASP ARG VAL GLY SEQRES 62 A 1127 PHE VAL ALA LYS ALA ILE PRO LEU TYR PHE ALA GLU GLU SEQRES 63 A 1127 TYR LYS ASP ASN VAL GLN PRO PHE TYR ASP TYR PRO PHE SEQRES 64 A 1127 ASN ILE GLY ASN ARG LEU LYS PRO LYS LYS ARG GLN PHE SEQRES 65 A 1127 LEU ASP LYS LYS GLU ARG VAL GLU LEU TRP GLN LYS ASN SEQRES 66 A 1127 LYS GLU LEU PHE LYS ASN TYR PRO SER GLU LYS LYS LYS SEQRES 67 A 1127 THR ASP LEU ALA TYR LEU ASP PHE LEU SER TRP LYS LYS SEQRES 68 A 1127 PHE GLU ARG GLU LEU ARG LEU ILE LYS ASN GLN ASP ILE SEQRES 69 A 1127 VAL THR TRP LEU MET PHE LYS GLU LEU PHE ASN MET ALA SEQRES 70 A 1127 THR VAL GLU GLY LEU LYS ILE GLY GLU ILE HIS LEU ARG SEQRES 71 A 1127 ASP ILE ASP THR ASN THR ALA ASN GLU GLU SER ASN ASN SEQRES 72 A 1127 ILE LEU ASN ARG ILE MET PRO MET LYS LEU PRO VAL LYS SEQRES 73 A 1127 THR TYR GLU THR ASP ASN LYS GLY ASN ILE LEU LYS GLU SEQRES 74 A 1127 ARG PRO LEU ALA THR PHE TYR ILE GLU GLU THR GLU THR SEQRES 75 A 1127 LYS VAL LEU LYS GLN GLY ASN PHE LYS ALA LEU VAL LYS SEQRES 76 A 1127 ASP ARG ARG LEU ASN GLY LEU PHE SER PHE ALA GLU THR SEQRES 77 A 1127 THR ASP LEU ASN LEU GLU GLU HIS PRO ILE SER LYS LEU SEQRES 78 A 1127 SER VAL ASP LEU GLU LEU ILE LYS TYR GLN THR THR ARG SEQRES 79 A 1127 ILE SER ILE PHE GLU MET THR LEU GLY LEU GLU LYS LYS SEQRES 80 A 1127 LEU ILE ASP LYS TYR SER THR LEU PRO THR ASP SER PHE SEQRES 81 A 1127 ARG ASN MET LEU GLU ARG TRP LEU GLN CYS LYS ALA ASN SEQRES 82 A 1127 ARG PRO GLU LEU LYS ASN TYR VAL ASN SER LEU ILE ALA SEQRES 83 A 1127 VAL ARG ASN ALA PHE SER HIS ASN GLN TYR PRO MET TYR SEQRES 84 A 1127 ASP ALA THR LEU PHE ALA GLU VAL LYS LYS PHE THR LEU SEQRES 85 A 1127 PHE PRO SER VAL ASP THR LYS LYS ILE GLU LEU ASN ILE SEQRES 86 A 1127 ALA PRO GLN LEU LEU GLU ILE VAL GLY LYS ALA ILE LYS SEQRES 87 A 1127 GLU ILE GLU LYS SER GLU ASN LYS ASN SEQRES 1 B 81 C G U C G C C G U C C A G SEQRES 2 B 81 C U C G A C C A G G A U G SEQRES 3 B 81 G G A A G U U G C A U C U SEQRES 4 B 81 G C C U U C U U U U U G A SEQRES 5 B 81 A A G G U A A A A A C A A SEQRES 6 B 81 C A U C G U C C A U U C C SEQRES 7 B 81 G A C HELIX 1 AA1 ASP A 41 LEU A 67 1 27 HELIX 2 AA2 TYR A 77 MET A 79 5 3 HELIX 3 AA3 GLY A 80 ALA A 89 1 10 HELIX 4 AA4 LYS A 91 PHE A 106 1 16 HELIX 5 AA5 PHE A 108 TYR A 114 1 7 HELIX 6 AA6 ASN A 124 LEU A 136 1 13 HELIX 7 AA7 SER A 137 SER A 160 1 24 HELIX 8 AA8 GLU A 174 TYR A 196 1 23 HELIX 9 AA9 THR A 241 LEU A 251 1 11 HELIX 10 AB1 ASP A 254 LYS A 264 1 11 HELIX 11 AB2 ASN A 273 PHE A 283 1 11 HELIX 12 AB3 THR A 300 ARG A 314 1 15 HELIX 13 AB4 LYS A 317 GLU A 321 1 5 HELIX 14 AB5 ARG A 324 GLU A 329 1 6 HELIX 15 AB6 ARG A 359 ASN A 371 1 13 HELIX 16 AB7 ARG A 413 GLN A 422 5 10 HELIX 17 AB8 PRO A 423 VAL A 430 1 8 HELIX 18 AB9 GLY A 488 THR A 492 5 5 HELIX 19 AC1 GLU A 501 LYS A 514 1 14 HELIX 20 AC2 SER A 517 ASN A 545 1 29 HELIX 21 AC3 SER A 550 GLN A 559 1 10 HELIX 22 AC4 LEU A 564 LEU A 568 5 5 HELIX 23 AC5 PRO A 569 GLY A 578 1 10 HELIX 24 AC6 ASP A 582 GLN A 611 1 30 HELIX 25 AC7 LYS A 624 GLN A 640 1 17 HELIX 26 AC8 ASN A 657 LEU A 670 1 14 HELIX 27 AC9 LEU A 670 ASN A 675 1 6 HELIX 28 AD1 ARG A 677 MET A 685 1 9 HELIX 29 AD2 PHE A 696 GLN A 701 5 6 HELIX 30 AD3 ASN A 707 GLY A 725 1 19 HELIX 31 AD4 LYS A 727 GLN A 729 5 3 HELIX 32 AD5 ASN A 730 ILE A 739 1 10 HELIX 33 AD6 ASN A 746 LYS A 755 1 10 HELIX 34 AD7 PHE A 765 ASN A 777 1 13 HELIX 35 AD8 TYR A 783 SER A 788 1 6 HELIX 36 AD9 GLY A 793 LYS A 808 1 16 HELIX 37 AE1 GLN A 812 ASP A 816 5 5 HELIX 38 AE2 ASP A 834 PHE A 849 1 16 HELIX 39 AE3 LYS A 850 TYR A 852 5 3 HELIX 40 AE4 PRO A 853 LYS A 858 1 6 HELIX 41 AE5 ASP A 860 ASN A 895 1 36 HELIX 42 AE6 HIS A 908 ILE A 912 5 5 HELIX 43 AE7 ASP A 913 GLU A 920 1 8 HELIX 44 AE8 ASN A 923 ARG A 927 5 5 HELIX 45 AE9 ASN A 969 LYS A 975 1 7 HELIX 46 AF1 ARG A 977 PHE A 983 1 7 HELIX 47 AF2 SER A 984 ALA A 986 5 3 HELIX 48 AF3 ASN A 992 HIS A 996 5 5 HELIX 49 AF4 LYS A 1000 TYR A 1032 1 33 HELIX 50 AF5 SER A 1039 LYS A 1051 1 13 HELIX 51 AF6 ARG A 1054 HIS A 1073 1 20 HELIX 52 AF7 ILE A 1105 ASN A 1125 1 21 SHEET 1 AA1 2 LYS A 214 LYS A 215 0 SHEET 2 AA1 2 ILE A 224 ASP A 225 -1 O ILE A 224 N LYS A 215 SHEET 1 AA2 2 CYS A 315 PRO A 316 0 SHEET 2 AA2 2 VAL A 354 ARG A 355 1 O ARG A 355 N CYS A 315 SHEET 1 AA3 2 LYS A 332 PRO A 334 0 SHEET 2 AA3 2 LYS A 350 THR A 352 -1 O ASN A 351 N VAL A 333 SHEET 1 AA4 3 GLU A 398 PHE A 411 0 SHEET 2 AA4 3 LEU A 377 ILE A 395 -1 N TYR A 391 O ARG A 402 SHEET 3 AA4 3 HIS A 450 TYR A 451 -1 O HIS A 450 N ASP A 382 SHEET 1 AA5 4 TYR A 443 ILE A 444 0 SHEET 2 AA5 4 LEU A 377 ILE A 395 -1 N HIS A 387 O TYR A 443 SHEET 3 AA5 4 LYS A 457 PHE A 462 -1 O LYS A 461 N ARG A 378 SHEET 4 AA5 4 ALA A 495 SER A 498 -1 O LEU A 497 N ILE A 458 SHEET 1 AA6 2 ASP A 476 LYS A 477 0 SHEET 2 AA6 2 SER A 483 LYS A 484 -1 O LYS A 484 N ASP A 476 SHEET 1 AA7 2 PHE A 819 ASN A 820 0 SHEET 2 AA7 2 PHE A 832 LEU A 833 -1 O LEU A 833 N PHE A 819 SHEET 1 AA8 3 LYS A 932 THR A 940 0 SHEET 2 AA8 3 ILE A 946 GLU A 958 -1 O LEU A 952 N THR A 937 SHEET 3 AA8 3 ILE A 998 SER A 999 1 O ILE A 998 N TYR A 956 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 268 0 0 52 20 0 0 6 9823 2 0 94 END